Detalles de la búsqueda
1.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
N Engl J Med
; 388(8): 706-718, 2023 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36812434
2.
TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM.
Endocr Pract
; 22(4): 396-405, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26574788
3.
Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
J Pediatr
; 167(6): 1389-96, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26394822
4.
Impact of acute bleeding on daily activities of patients with congenital hemophilia with inhibitors and their caregivers and families: observations from the Dosing Observational Study in Hemophilia (DOSE).
Value Health
; 17(6): 744-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236999
5.
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy.
Blood Adv
; 7(19): 5671-5679, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36490302
6.
Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing observational study in hemophilia.
Value Health
; 15(6): 916-25, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22999142
7.
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B.
Blood Adv
; 3(21): 3241-3247, 2019 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31698454
8.
Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Obstet Gynecol
; 111(1): 67-76, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18165394
9.
Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
Obstet Gynecol
; 112(5): 1053-60, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18978105
10.
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study.
Blood Coagul Fibrinolysis
; 27(7): 753-760, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26761583
11.
Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry.
Blood Coagul Fibrinolysis
; 27(7): 761-769, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467981
12.
Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program.
Int J Pediatr Endocrinol
; 2015(1): 1, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25904938
13.
Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Growth Horm IGF Res
; 25(6): 286-93, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26363846
14.
Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry.
Int J Pediatr Endocrinol
; 2012(1): 15, 2012 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22682146
15.
Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE).
J Blood Med
; 3: 131-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23152717
16.
Impact of age and duration of growth hormone therapy in children with Turner syndrome.
Horm Res Paediatr
; 76(6): 392-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22156541
17.
Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®.
Int J Pediatr Endocrinol
; 2011: 6, 2011 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-21899782
18.
Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study.
Int J Pediatr Endocrinol
; 2010: 494656, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20981140
19.
Endometrial safety of ultra-low-dose estradiol vaginal tablets.
Obstet Gynecol
; 116(4): 876-883, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20859151
20.
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project.
J Blood Med
; 5: 1-3, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24470784
Resultados
1 -
20
de 20
1
Próxima >
>>